Please enable JavaScript to continue using this application.

Compare $ACET vs $INMB | Chartloom

Compare

$ACET vs $INMB

Adicet Bio Inc · INmune Bio Inc

ACET

Adicet Bio Inc

INMB

INmune Bio Inc

Compare $ACET vs $INMB

Comparing Adicet Bio Inc and INmune Bio Inc

ACETAdicet Bio Inc

INMBINmune Bio Inc

ACETAdicet Bio Inc

Market cap

$52M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-36.4%

52W performance

-62.2%

FCF yield

-162.0%

INMBINmune Bio Inc

Market cap

$50M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

22.7%

52W performance

-6.0%

FCF yield

-31.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACET

INMB

Detailed metrics comparison

ACET

Adicet Bio Inc

INMB

INmune Bio Inc

Market Cap

ACET$52M

INMB$50M

Enterprise Value

ACET$20M

INMB$32M

Price

ACET$5.61

INMB$1.89

P/E Ratio

ACETN/A

INMBN/A

P/S Ratio

ACET1.57x

INMB1,071.30x

EV/Sales

ACET0.74x

INMB703.08x

EV/EBITDA

ACET0.00x

INMB0.00x

P/B Ratio

ACET0.51x

INMB2.63x

P/FCF Ratio

ACETN/A

INMBN/A

EV/FCF

ACET-0.24x

INMB-2.02x

PEG Ratio

ACETN/A

INMBN/A

Forward P/E (NTM)

ACETN/A

INMBN/A

Forward P/S (NTM)

ACETN/A

INMBN/A

Revenue (TTM)

ACET$0

INMB$0

Revenue Growth (YoY)

ACETN/A

INMB-100.0%

Forward Rev Growth

ACET171.3%

INMB150.6%

Gross Margin (TTM)

ACET0.0%

INMB0.0%

Operating Margin (TTM)

ACET0.0%

INMB0.0%

EBITDA Margin (TTM)

ACET0.0%

INMB0.0%

Net Margin (TTM)

ACET0.0%

INMB0.0%

FCF Margin (TTM)

ACETN/A

INMBN/A

Net Income (TTM)

ACET$-99M

INMB$-18M

FCF (TTM)

ACET$-85M

INMB$-16M

EPS (TTM)

ACET-$9.21

INMB-$0.69

ROE (TTM)

ACET-7490.0%

INMB-8287.0%

ROA (TTM)

ACET-6087.0%

INMB-6223.0%

ROIC (TTM)

ACET-7437.0%

INMB-8287.0%

Cash

ACET$33M

INMB$18M

Debt

ACET$798K

INMB$0

Net Cash/Debt

ACET$32M

INMB$18M

Current Ratio (TTM)

ACET6.71x

INMB4.04x

Quick Ratio (TTM)

ACET6.59x

INMB3.94x

Debt/Equity (TTM)

ACET0.01x

INMB0.00x

Debt/Assets (TTM)

ACET0.0%

INMB0.0%

Interest Coverage (TTM)

ACETN/A

INMBN/A

Net Debt/EBITDA (TTM)

ACET0.00x

INMB0.00x

Beta

ACET1.68

INMB0.91

52W Performance

ACET-62.2%

INMB-6.0%

YTD Performance

ACET-36.4%

INMB22.7%

% from 52W High

ACET-67.8%

INMB-27.3%

% from 52W Low

ACET1.1%

INMB73.4%

Asset Turnover (TTM)

ACET0.13x

INMB0.00x

FCF Yield (TTM)

ACET-162.0%

INMB-31.3%

Earnings Yield (TTM)

ACET-188.7%

INMB-36.6%

Dividend Yield (TTM)

ACETN/A

INMBN/A

Rule of 40

ACET0.0

INMB-100.0

EV/GP/RG

ACETN/A

INMBN/A

Ticker research

View ACET research View INMB research

Metric	ACET Adicet Bio Inc	INMB INmune Bio Inc
Market & Valuation
Market Cap	$52M	$50M
Enterprise Value	$20M	$32M
Price	$5.61	$1.89
P/E Ratio	N/A	N/A
P/S Ratio	1.57x	1,071.30x
EV/Sales	0.74x	703.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.51x	2.63x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.24x	-2.02x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	-100.0%
Forward Rev Growth	171.3%	150.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-99M	$-18M
FCF (TTM)	$-85M	$-16M
EPS (TTM)	-$9.21	-$0.69
ROE (TTM)	-7490.0%	-8287.0%
ROA (TTM)	-6087.0%	-6223.0%
ROIC (TTM)	-7437.0%	-8287.0%
Financial Health
Cash	$33M	$18M
Debt	$798K	$0
Net Cash/Debt	$32M	$18M
Current Ratio (TTM)	6.71x	4.04x
Quick Ratio (TTM)	6.59x	3.94x
Debt/Equity (TTM)	0.01x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.68	0.91
52W Performance	-62.2%	-6.0%
YTD Performance	-36.4%	22.7%
% from 52W High	-67.8%	-27.3%
% from 52W Low	1.1%	73.4%
Efficiency & Yields
Asset Turnover (TTM)	0.13x	0.00x
FCF Yield (TTM)	-162.0%	-31.3%
Earnings Yield (TTM)	-188.7%	-36.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-100.0
EV/GP/RG	N/A	N/A
Ticker research	View ACET research	View INMB research

Valuation

P/S Ratio

ACET

1.57x

INMB

1,071.30x

EV/FCF

INMB

-2.02x

ACET

-0.24x

Growth & revenue

Revenue Growth TTM

INMB

-100.0%

Forward Revenue Growth

ACET

171.3%

INMB

150.6%

Profitability & performance

Gross Margin

ACET

0.0%

INMB

0.0%

ROE

ACET

-7490.0%

INMB

-8287.0%

FCF Yield %

INMB

-31.3%

ACET

-162.0%

52-Week Performance

INMB

-6.0%

ACET

-62.2%

Detailed metrics comparison

ACET

Adicet Bio Inc

INMB

INmune Bio Inc

Market Cap

ACET$52M

INMB$50M

Enterprise Value

ACET$20M

INMB$32M

Price

ACET$5.61

INMB$1.89

P/E Ratio

ACETN/A

INMBN/A

P/S Ratio

ACET1.57x

INMB1,071.30x

EV/Sales

ACET0.74x

INMB703.08x

EV/EBITDA

ACET0.00x

INMB0.00x

P/B Ratio

ACET0.51x

INMB2.63x

P/FCF Ratio

ACETN/A

INMBN/A

EV/FCF

ACET-0.24x

INMB-2.02x

PEG Ratio

ACETN/A

INMBN/A

Forward P/E (NTM)

ACETN/A

INMBN/A

Forward P/S (NTM)

ACETN/A

INMBN/A

Revenue (TTM)

ACET$0

INMB$0

Revenue Growth (YoY)

ACETN/A

INMB-100.0%

Forward Rev Growth

ACET171.3%

INMB150.6%

Gross Margin (TTM)

ACET0.0%

INMB0.0%

Operating Margin (TTM)

ACET0.0%

INMB0.0%

EBITDA Margin (TTM)

ACET0.0%

INMB0.0%

Net Margin (TTM)

ACET0.0%

INMB0.0%

FCF Margin (TTM)

ACETN/A

INMBN/A

Net Income (TTM)

ACET$-99M

INMB$-18M

FCF (TTM)

ACET$-85M

INMB$-16M

EPS (TTM)

ACET-$9.21

INMB-$0.69

ROE (TTM)

ACET-7490.0%

INMB-8287.0%

ROA (TTM)

ACET-6087.0%

INMB-6223.0%

ROIC (TTM)

ACET-7437.0%

INMB-8287.0%

Cash

ACET$33M

INMB$18M

Debt

ACET$798K

INMB$0

Net Cash/Debt

ACET$32M

INMB$18M

Current Ratio (TTM)

ACET6.71x

INMB4.04x

Quick Ratio (TTM)

ACET6.59x

INMB3.94x

Debt/Equity (TTM)

ACET0.01x

INMB0.00x

Debt/Assets (TTM)

ACET0.0%

INMB0.0%

Interest Coverage (TTM)

ACETN/A

INMBN/A

Net Debt/EBITDA (TTM)

ACET0.00x

INMB0.00x

Beta

ACET1.68

INMB0.91

52W Performance

ACET-62.2%

INMB-6.0%

YTD Performance

ACET-36.4%

INMB22.7%

% from 52W High

ACET-67.8%

INMB-27.3%

% from 52W Low

ACET1.1%

INMB73.4%

Asset Turnover (TTM)

ACET0.13x

INMB0.00x

FCF Yield (TTM)

ACET-162.0%

INMB-31.3%

Earnings Yield (TTM)

ACET-188.7%

INMB-36.6%

Dividend Yield (TTM)

ACETN/A

INMBN/A

Rule of 40

ACET0.0

INMB-100.0

EV/GP/RG

ACETN/A

INMBN/A

Ticker research

View ACET research View INMB research

Metric	ACET Adicet Bio Inc	INMB INmune Bio Inc
Market & Valuation
Market Cap	$52M	$50M
Enterprise Value	$20M	$32M
Price	$5.61	$1.89
P/E Ratio	N/A	N/A
P/S Ratio	1.57x	1,071.30x
EV/Sales	0.74x	703.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.51x	2.63x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.24x	-2.02x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	-100.0%
Forward Rev Growth	171.3%	150.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-99M	$-18M
FCF (TTM)	$-85M	$-16M
EPS (TTM)	-$9.21	-$0.69
ROE (TTM)	-7490.0%	-8287.0%
ROA (TTM)	-6087.0%	-6223.0%
ROIC (TTM)	-7437.0%	-8287.0%
Financial Health
Cash	$33M	$18M
Debt	$798K	$0
Net Cash/Debt	$32M	$18M
Current Ratio (TTM)	6.71x	4.04x
Quick Ratio (TTM)	6.59x	3.94x
Debt/Equity (TTM)	0.01x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.68	0.91
52W Performance	-62.2%	-6.0%
YTD Performance	-36.4%	22.7%
% from 52W High	-67.8%	-27.3%
% from 52W Low	1.1%	73.4%
Efficiency & Yields
Asset Turnover (TTM)	0.13x	0.00x
FCF Yield (TTM)	-162.0%	-31.3%
Earnings Yield (TTM)	-188.7%	-36.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-100.0
EV/GP/RG	N/A	N/A
Ticker research	View ACET research	View INMB research